NEW LAWSUIT ALLEGES DRUG PATENT COLLUSION IN THE HIV MARKET


Photo: Marvin Joseph/The Washington Post via Getty Images

Yesterday, a lawsuit was filed by AIDS activists and unions alleging Gilead conspired with other drug companies to block generic competition in the HIV market according to Stat News. The lawsuit alleges that Gilead made deals with Bristol-Myers Squibb and Janssen to use only each others’ products in these cocktails, even after the patents expired.

Notable Quotes: “This gross profiteering explains why less than half of people living with HIV in the U.S. are virally suppressed, one of the lowest rates among the world’s high-income countries.” Brenda Goodrow, one of the plaintiffs in the suit